retatrutide peptide eli lilly ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Retatrutide for Weight Loss: TRIUMPH-1

ns not significant

Dang VD, Jella KK, Ragheb RRT et al (2017) Lipidomic and proteomic analysis of exosomes from mouse cortical collecting duct cells

If youre maintaining results after stopping a GLP-1 medication, red light therapy may be a helpful adjunct alongside protein, training, and your providers guidance

If anything, the rise of pharmacological treatments for obesity increases the importance of integrating medication, lifestyle support, and skilled communication and advice

For now, they offer an important new tool in addressing severe pediatric obesity, potentially delaying or even eliminating the need for bariatric surgery for more patients.

The phase 2 and phase 3 clinical trials use a systemic stepwise titration to gradually increase the retatrutide dose to help the body adjust and reach the therapeutically effective dose with minimal side effects